Cladribine
Formulations: - Oral > Solid > tablet: 10 mg Indications: - Multiple sclerosis Source: EML workbook import
MOQ: 1
Kes0.00
Product image unavailable
Rituximab
Vendor: Marketplace supplier
Formulations:
- Parenteral > General injections > IV: 500 mg per 50 mL in 50 mL vial
- Parenteral > General injections > IV: 100 mg per 10 mL in 10 mL vial; 500 mg per 50 mL in 50 mL vial
Indications:
- Multiple sclerosis
- Follicular lymphoma
- Diffuse large B-cell lymphoma, not otherwise specified
- Chronic lymphocytic leukaemia or small lymphocytic lymphoma
- Burkitt lymphoma including Burkitt leukaemia
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Kes0.00
Availability
Supplier and price will be confirmed during RFQ.
Formulations:
- Parenteral > General injections > IV: 500 mg per 50 mL in 50 mL vial
- Parenteral > General injections > IV: 100 mg per 10 mL in 10 mL vial; 500 mg per 50 mL in 50 mL vial
Indications:
- Multiple sclerosis
- Follicular lymphoma
- Diffuse large B-cell lymphoma, not otherwise specified
- Chronic lymphocytic leukaemia or small lymphocytic lymphoma
- Burkitt lymphoma including Burkitt leukaemia
Source: EML workbook import
Similar Products
Glatiramer Acetate
Formulations: - Parenteral > General injections > SC: 20 mg per mL; 40 mg per mL Parenteral > General injections > SC: 20 mg per mL in pre-filled syringe; 40 mg per mL in pre-filled syringe Indications: - Relapsing-remitting multiple sclerosis - Multiple sclerosis Source: EML workbook import
MOQ: 1
Kes0.00
Carbetocin
Formulations: - Parenteral > General injections > IV: 100 µg per mL (heat stable) Indications: - Postpartum haemorrhage Source: EML workbook import
MOQ: 1
Kes0.00
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.